Open Access Mini Review

Biotechnology and Bioengineering Tools in COVID-19 Diagnostics - CRISPR and Beyond

Rwik Sen*

Department of Biomedical Engineering, Active Motif, USA.

Corresponding Author

Received Date: December 11, 2020;  Published Date: December 22, 2020


Advances in bioengineering and biotechnology are an urgent need of the hour because of the ongoing pandemic of COVID-19. Coronavirus disease 2019 or COVID-19 is caused by SARS-CoV-2 which is a strain of a coronavirus called SARS-CoV or Severe Acute Respiratory Syndrome Corona Virus. Globally, COVID-19 has claimed lives 1,575,810 and infected 69,239,671 people. In this direction, biotechnological and bioengineering endeavors have shown several promising results to control the pandemic, which are discussed in this mini review.

Signup for Newsletter
Scroll to Top